Lataa...
Synergistic Anticancer Action of Lysosomal Membrane Permeabilization and Glycolysis Inhibition
We investigated the in vitro and in vivo anticancer effect of combining lysosomal membrane permeabilization (LMP)-inducing agent N-dodecylimidazole (NDI) with glycolytic inhibitor 2-deoxy-d-glucose (2DG). NDI-triggered LMP and 2DG-mediated glycolysis block synergized in inducing rapid ATP depletion,...
Tallennettuna:
| Julkaisussa: | J Biol Chem |
|---|---|
| Päätekijät: | , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Biochemistry and Molecular Biology
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5087715/ https://ncbi.nlm.nih.gov/pubmed/27587392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M116.752113 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|